Epidemiology and Genetics of Preserved Ratio Impaired SpiroMetry (PRISm): An Analysis of UK Biobank - Higbee, Daniel; Granell, Raquel; Davey-Smith, George; Dodd, James W (medRxiv, 2021)
The authors have withdrawn this manuscript version because the FEV1 percent predicted variable (UK biobank data field 20154) that was used was to determine spirometric pattern was constructed in only “healthy never smokers” or heavy smokers. This means the paper is affected by selection bias and is not generalizable. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementDr Dodd reports non-financial support from Chesi, personal fees from Chesi, Boerhinger Ingelheim, AstraZeneca, personal fees from GSK. All outside the submitted workFunding StatementFunding: This work was supported by the Medical Research Council and the University of Bristol Integrative Epidemiology Unit (MC_UU_00011). MRC CARP Fellowship (Grant ref: MR/T005114/1)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/A Data already collected by UKBiobank. No ethical approval was required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWithin 4 weeks of publication our GWAS results will be available online from https://gwas.mrcieu.ac.uk/